Clinical Trial Update: Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of Azficel-T for vocal fold scarring and age-related dysphonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Dysphonia
• Dysphonia Resulting From Vocal Fold Scarring

Drugs mentioned

• Azficel-T (Azficel-T)

Snippet

Sponsor: Castle Creek Biosciences, LLC. | Conditions: Dysphonia Resulting From Vocal Fold Scarring, Age-related Dysphonia | Phase 2 | Status: COMPLETED | Results posted: 2021-06-03